companydata.dkcompanydata.dk

Serenova A/S: Financial statements 2021

CVR: 30532228

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Serenova A/S (CVR 30532228) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -43,552 and a net result of DKK 12,888,491 compared with DKK -83,198,438 the year before. Equity in the 2021 report amounted to DKK 20,655,146. The solvency ratio was 58.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -43,552
Profit/Loss
DKK 12,888,491
Equity
DKK 20,655,146
Total Assets
DKK 35,534,797
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--44K12.9M20.7M1
2020--54K-83.2M7.8M1
2019--36K-128.5M91M-
2018-13K-54.8M219.4M-
2017--4.3M274.1M274.2M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Serenova A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Serenova A/S: The 2020 annual report is outMay 7, 2021

Serenova A/S has published its annual report for 2020. Gross profit came to DKK -54,173, and the net result was DKK -83,198,438.

About Serenova A/S

Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.

Source: annual report 2025, Danish Business Authority